Craig D. Fisher - Concepedia

Author

Craig D. Fisher

Also Known As

C D Fisher, C FISHER, C Fisher, C. D. Fisher, C. Fisher, C.D. Fisher, Craig D. Fisher, Craig Fisher, Cynthia L. Fisher, Fisher, Craig

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

University of Arizona Institute of Pharmacology Takeda (United States)University of Rhode Island Brookhaven National Laboratory

About

Craig D. Fisher is an author at University of Arizona specializing in medicine, pharmacology, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	821
2	Natural Sciences	2	2	163
3	Social Sciences	2	2	164
4	Biochemistry	2	2	163
5	Health Sciences	1	1	113

Craig D. Fisher

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease Craig D. Fisher, Andrew J. Lickteig, Lisa M. Augustine, Drug Metabolism and Disposition	2009	342
Diversity in Antioxidant Response Enzymes in Progressive Stages of Human Nonalcoholic Fatty Liver Disease Rhiannon N. Hardwick, Craig D. Fisher, Mark J. Canet, Drug Metabolism and Disposition	2010	194
Analysis of Global and Absorption, Distribution, Metabolism, and Elimination Gene Expression in the Progressive Stages of Human Nonalcoholic Fatty Liver Disease April D. Lake, Petr Novák, Craig D. Fisher, Drug Metabolism and Disposition	2011	160
Neutron capture therapy of the 9l rat gliosarcoma using the P-boronophenylalanine-fructose complex Jeffrey A. Coderre, Terry M. Button, Peggy L. Micca, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyMedicineP-boronophenylalanine-fructose ComplexRadiopharmaceutical TherapyNeutron Capture Therapy	1994	150
Predictors of fear of hypoglycemia in adolescents with type 1 diabetes and their parents Linda Gonder‐Frederick, Craig D. Fisher, Lee M. Ritterband, Pediatric Diabetes	2006	148
Variations in ATP-Binding Cassette Transporter Regulation during the Progression of Human Nonalcoholic Fatty Liver Disease Rhiannon N. Hardwick, Craig D. Fisher, Mark J. Canet, Drug Metabolism and Disposition	2011	138
Interaction between the serotonin transporter gene and neuroticism in cigarette smoking behavior S Hu, Cindy Brody, Craig D. Fisher, Molecular Psychiatry Tobacco ControlNeurobiological MechanismPsychiatryNeurophysiologyAddiction	2000	135
Induction of Drug-Metabolizing Enzymes by Garlic and Allyl Sulfide Compounds via Activation of Constitutive Androstane Receptor and Nuclear Factor E2-Related Factor 2 Craig D. Fisher, Lisa M. Augustine, Jonathan Maher, Drug Metabolism and Disposition	2007	128
Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats Craig D. Fisher, Andrew J. Lickteig, Lisa M. Augustine, European Journal of Pharmacology PathologyFatty Liver DiseaseObesityMetabolic SyndromeMetabolic Associated Steatotic Liver Disease	2009	113
First-in-Class Pan Caspase Inhibitor Developed for the Treatment of Liver Disease Steven D. Linton, Teresa Aja, Robert A. Armstrong, Journal of Medicinal Chemistry PathologyPharmacotherapyOxidative StressMedicinal ChemistryP4 Oxamides	2005	105

Page 1